MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Characteristics and Treatment Response to OnabotulinumtoxinA of Patients From CD-PROBE With Retrocollis Subtype of Cervical Dystonia

    K. Dashtipour, J. Jankovic, D. Charles, S. Mehta, M. Schwartz, M. Sadeghi (Loma Linda, USA)

    Objective: To describe characteristics and treatment response to onabotulinumtoxinA (onabotA) of patients with retrocollis (RC). Background: The CD-PROBE trial of onabotA included patients with RC,…
  • 2022 International Congress

    Discrimination in Healthcare for Parkinsonism Across Sexual and Gender Minority Groups

    E. Bayram, K. Wyman-Chick, L. Damron, I. Litvan (La Jolla, USA)

    Objective: To compare perceived discrimination in healthcare across men, women and LBGTQ+ people with parkinsonism Background: Stigma, often experienced by people with parkinsonism and care…
  • 2022 International Congress

    Efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease patients with motor fluctuations: a multicenter randomized open-label cross-over trial

    HJ. Chang, J. Park, S. Oh, CW. Shin, JW. Cho, JY. Lee (Seoul, Republic of Korea)

    Objective: This study aimed to assess the efficacy of levodopa/benserazide dispersible tablet on delayed ON in Parkinson’s disease (PD) patients with motor fluctuation. Background: Delayed…
  • 2022 International Congress

    Clinical, environmental, and Technology-based gait measures in PD patients from a rural area in southwestern Colombia: a case-control pilot study

    B. Muñoz-Ospina, H. Clavijo-Moran, D. álvarez-García, A. Navarro Cadavid, I. F Mata, J. Orozco Velez (Cali, Colombia)

    Objective: Describe the clinical characteristics, environmental exposures, and technology-based gait assessment of a sample of Parkinson’s disease patients in a rural area in southwestern of…
  • 2022 International Congress

    Factors that negatively impact the sexual function of men living with Parkinson’s disease

    B. de Souza (São Paulo, Brazil)

    Objective: To investigate the impact of motor, non-motor function, and relationship quality on sexual function in men living with PD. Background: Among the non-motor alteration…
  • 2022 International Congress

    Sleep-wake disturbance in Creutzfeldt-Jakob disease mimicking fatal familial insomnia

    T. Thammongkolchai, A. Charoensri, S. Liamsombut, P. Termsarasab (Bangkok, Thailand)

    Objective: To report a patient with sleep-wake disturbance mimicking fatal familial insomnia Background: Sleep disturbances are well recognized in fatal familial insomnia (FFI) which is…
  • 2022 International Congress

    Different longitudinal manifestations in dopaminergic dysfunction in REM sleep behavior disorder

    P. Wu, H. Yu (Shanghai, China)

    Objective: To explore the different patterns of dopaminergic dysfunction between iRBD patients who convert to Parkinson’s disease (PD)/dementia with Lewy bodies (DLB) and those who…
  • 2022 International Congress

    Psychotherapy as a potential treatment for neuropsychiatric startle syndromes of Latah – a case report

    GB. Eow, TT. Lim, K. Tan, YY. Beh (Georgetown, Malaysia)

    Objective: Our report aims to discuss psychotherapy as a treatment modality for Latah. Background: Latah is a culture-specific startle syndrome (classically identified in Malaysian/Indonesian patients)…
  • 2022 International Congress

    Protective approach targeting NF-kB/ Nrf2 signaling and neuroinflammation using Apigenin in LPS induced Parkinsonism in experimental rats

    S. Singh (Moga, India)

    Objective: 1. Apigenin as a protective strategy to prevent neuroinflammation in PD.2. To find behavioral, neurochemical and histopathological changes in LPS induced PD. Background: Parkinson’s…
  • 2022 International Congress

    A rare case of Hyperkinetic Movement disorder

    P. A, T. K, S. S, C. P, P. Peter (SALEM, India)

    Objective: We present a case of hyperkinetic movement disorder in a 47 year old male with 3 year history of behavioural changes, chorea and dystonia…
  • « Previous Page
  • 1
  • …
  • 92
  • 93
  • 94
  • 95
  • 96
  • …
  • 153
  • Next Page »
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley